Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial - The Lancet Haematology
Switching among anticoagulants (A) between non-vitamin K antagonist... | Download Scientific Diagram
New oral anticoagulants (NOAC) WATAG guidelines
Updated Guidelines on Outpatient Anticoagulation | AAFP
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic
View Image
Switching Oral Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention ∗ | JACC: Cardiovascular Interventions
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Hein Heidbuchel1, M.D., Ph.D., Peter Verhamme1, - ppt download
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
RxNotes - It is important when switching between warfarin and DOACs (direct oral anticoagulation) to maintain adequate anticoagulation. 🇺🇸NOTE FOR USA: The American recommendations for switching from warfarin to rivaroxaban is INR <
PharmD on Twitter: "#GuideLines for switching between #Anticoagulants https://t.co/tmYuJDq6rm" / Twitter
Direct Oral Anticoagulants: A User's Guide | Consultant360
Anticoagulants | Health Navigator NZ
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Switching Anticoagulants V1.2 Oct 2022 - Library
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide | SpringerLink
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation - Province of British Columbia
